Original language | English |
---|---|
Pages (from-to) | 3667-3670 |
Number of pages | 4 |
Journal | Allergy: European Journal of Allergy and Clinical Immunology |
Volume | 77 |
Issue number | 12 |
Early online date | 2022 |
DOIs |
|
Publication status | Published - Dec 2022 |
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, No. 12, 12.2022, p. 3667-3670.
Research output: Contribution to journal › Comment/Letter to the editor › Academic
TY - JOUR
T1 - Migration and allergic diseases
T2 - Findings from a population-based study in adults in Amsterdam, the Netherlands
AU - Amoah, Abena S.
AU - Prins, Maria
AU - Bel, Elisabeth H. D.
AU - Fokkens, Wytske J.
AU - Zwinderman, Aeilko H.
AU - Yazdanbakhsh, Maria
AU - Maitland-van der Zee, Anke H.
AU - van Ree, Ronald
N1 - Funding Information: Professor Anke H. Maitland‐van der Zee is the principal investigator of a P4O2 (Precision Medicine for more Oxygen) public‐private partnership sponsored by Health Holland involving many private partners that contribute in cash and/or in kind (Boehringer Ingelheim, Breathomix, Fluidda, Ortec Logiqcare, Philips, Quantib‐U, Smartfish, SODAQ, Thirona, TopMD and Novartis). Furthermore, Professor Maitland‐van der Zee has received unrestricted research grants from GSK, Boehringer Ingelheim and Vertex, and has had received consulting fees paid to her institution from Boehringer Ingelheim and AstraZeneca. She has also received honoraria for lectures paid to her institution from GlaxoSmithKline; outside the submitted work. Funding Information: The HELIUS study is conducted by the Amsterdam University Medical Centers, location AMC and the Public Health Service of Amsterdam. Both organizations provided core support for HELIUS. The HELIUS study is also funded by the Dutch Heart Foundation (Grant number: 2010T084 [K Stronks]), the Netherlands Organization for Health Research and Development—ZonMw (Grant number: 200500003 [K Stronks]), the European Union (FP‐7 ‐ 278901 [K Stronks]) and the European Fund for the Integration of Third‐Country Nationals‐EIF (2013EIF013 [K Stronks]).
PY - 2022/12
Y1 - 2022/12
UR - http://www.scopus.com/inward/record.url?scp=85134392101&partnerID=8YFLogxK
U2 - https://doi.org/10.1111/all.15427
DO - https://doi.org/10.1111/all.15427
M3 - Comment/Letter to the editor
C2 - 35791844
SN - 0105-4538
VL - 77
SP - 3667
EP - 3670
JO - Allergy: European Journal of Allergy and Clinical Immunology
JF - Allergy: European Journal of Allergy and Clinical Immunology
IS - 12
ER -